David Volkin
14Patents
10h-index
11Co-inventors
65Inventor score
Filing activity: Apr 1, 1992 → May 10, 2006
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6251678A | Human papillomavirus vaccine formulations | Emerging Cross-Sectional Technologies | 41 | Expired |
| US5932223A | Rotavirus vaccine formulations | Chemistry; Metallurgy | 33 | Expired |
| US6290967A | Stabilizers for lyophilized vaccines | Emerging Cross-Sectional Technologies | 22 | Expired |
| US6616931B1 | Rotavirus vaccine formulations | Chemistry; Metallurgy | 22 | Expired |
| US6210683A | Stabilizers containing recombinant human serum albumin for live virus vaccines | Emerging Cross-Sectional Technologies | 19 | Expired |
| US5348941A | Stabilizers for fibroblast growth factors | Human Necessities | 19 | Expired |
| US6051238A | Stabilizers for lyophilized mumps vaccines | Emerging Cross-Sectional Technologies | 17 | Expired |
| US6245568A | Human papilloma virus vaccine with disassembled and reassembled virus-like particles | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6403098B1 | Rotavirus vaccine formulations | Chemistry; Metallurgy | 13 | Expired |
| US7456009B2 | Adenovirus formulations | Chemistry; Metallurgy | 11 | Expired |
| US6387695B1 | DNA pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof | Human Necessities | 9 | Expired |
| US7927870B2 | DNA vaccine formulations | Chemistry; Metallurgy | 6 | Active |
| US6358744B1 | Stabilized human papillomavirus formulations | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7351415B2 | Adenovirus formulations | Chemistry; Metallurgy | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.